ISSN: 0269-9370

Journal Home

Journal Guideline

AIDS Q1 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

AIDS is a journal indexed in SJR in Infectious Diseases and Immunology with an H index of 230. It has an SJR impact factor of 1,401 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,401.

AIDS focuses its scope in these topics and keywords: hiv, antiretroviral, patients, hivinfected, therapy, cell, infection, cd, virus, viral, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology (Q1) Immunology and Allergy (Q1) Immunology and Allergy (Q1) Infectious Diseases (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,401

SJR Impact factor

230

H Index

338

Total Docs (Last Year)

1002

Total Docs (3 years)

10496

Total Refs

2553

Total Cites (3 years)

785

Citable Docs (3 years)

2.53

Cites/Doc (2 years)

31.05

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Microbiology Q1
Clinical Microbiology Reviews Q1
The Lancet Infectious Diseases Q1
Cellular and Molecular Immunology Q1
Drug Resistance Updates Q1

Compare this journals

Aims and Scope

Best articles by citations

Efficacy and safety of combination therapy with interferon-a2b and ribavirin for chronic hepatitis C in HIV-infected patients

Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients

Intracellular cytokines in the acute response to highly active antiretroviral therapy

Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients

Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack)

Reversible renal failure caused by a microsporidian infection

Predictive value of repeated measurements of CD4 lymphocyte counts on progression to AIDS

Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants

Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load

Maternal HIV infection is an important health determinant in non-HIV-infected infants

Sir, Esophageal candidiasis and immunodeficiency associated with acute HIV infection

SHOW MORE ARTICLES

Reversal of accelerated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-CSF (Filgrastim) therapy in patients with AIDS

Failure to infect lower primate species with SIVcpz

Sexual behaviour in a rural high HIV prevalence South African community

Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results

Isolation of Mycobacterium interjectum in an AIDS patient with diarrhea

Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia

Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients

Efavirenz-rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patients

Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance

Comparison of eight commercial test kits for detecting anti-HIV antibodies in saliva specimens